These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blood doping: risks to athletes' health and strategies for detection. Oliveira CD; Bairros AV; Yonamine M Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400 [TBL] [Abstract][Full Text] [Related]
3. Artificial oxygen carriers--the new doping threat in endurance sport? Schumacher YO; Schmid A; Dinkelmann S; Berg A; Northoff H Int J Sports Med; 2001 Nov; 22(8):566-71. PubMed ID: 11719891 [TBL] [Abstract][Full Text] [Related]
4. Biochemistry, physiology, and complications of blood doping: facts and speculation. Lippi G; Franchini M; Salvagno GL; Guidi GC Crit Rev Clin Lab Sci; 2006; 43(4):349-91. PubMed ID: 16769597 [TBL] [Abstract][Full Text] [Related]
5. Doping with artificial oxygen carriers: an update. Schumacher YO; Ashenden M Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124 [TBL] [Abstract][Full Text] [Related]
6. Blood transfusions in athletes. Old dogmas, new tricks. Lippi G; Banfi G Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813 [TBL] [Abstract][Full Text] [Related]
7. [The new frontiers of blood doping]. Lippi G; Franchini M Recenti Prog Med; 2002 Jan; 93(1):1-8. PubMed ID: 11850993 [TBL] [Abstract][Full Text] [Related]
8. Blood doping: the flip side of transfusion and transfusion alternatives. Cacic DL; Hervig T; Seghatchian J Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798 [TBL] [Abstract][Full Text] [Related]
11. [Oxygen blood transport and doping]. Audran M; Connes P; Varlet-Marie E Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of a perfluorocarbon blood substitute to macrophages in vitro. Bucala R; Kawakami M; Cerami A Science; 1983 May; 220(4600):965-7. PubMed ID: 6844922 [TBL] [Abstract][Full Text] [Related]
14. [Recent advances in the detection of human erythropoietin and human growth hormone doping]. Guo L; Zhang Z; Tang J; Xie J Se Pu; 2008 Jul; 26(4):437-43. PubMed ID: 18959238 [TBL] [Abstract][Full Text] [Related]
15. The biochemistry of drugs and doping methods used to enhance aerobic sport performance. Cooper CE Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283 [TBL] [Abstract][Full Text] [Related]
17. Doping and musculoskeletal system: short-term and long-lasting effects of doping agents. Nikolopoulos DD; Spiliopoulou C; Theocharis SE Fundam Clin Pharmacol; 2011 Oct; 25(5):535-63. PubMed ID: 21039821 [TBL] [Abstract][Full Text] [Related]
18. Influence of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man. Fukushima K; Nakamura M; Hinuma K Prog Clin Biol Res; 1983; 122():291-8. PubMed ID: 6878373 [No Abstract] [Full Text] [Related]
19. The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes. Striegel H; Rössner D; Simon P; Niess AM Int J Sports Med; 2005 Apr; 26(3):238-43. PubMed ID: 15776342 [TBL] [Abstract][Full Text] [Related]